Comparison of microwave and magnetic nanoparticle hyperthermia radiosensitization in murine breast tumors

Andrew J. Giustini; Alicia A. Petryk; Paul J. Hoopes

doi:10.1117/12.876515

22 February 2011 Comparison of microwave and magnetic nanoparticle hyperthermia radiosensitization in murine breast tumors

Andrew J. Giustini, Alicia A. Petryk, Paul J. Hoopes

Author Affiliations +

Proceedings Volume 7901, Energy-based Treatment of Tissue and Assessment VI; 79010E (2011) https://doi.org/10.1117/12.876515
Event: SPIE BiOS, 2011, San Francisco, California, United States

Abstract

Hyperthermia has been shown to be an effective radiosensitizer. Its utility as a clinical modality has been limited by a minimally selective tumor sensitivity and the inability to be delivered in a tumor-specific manner. Recent in vivo studies (rodent and human) have shown that cancer cell-specific cytotoxicity can be effectively and safely delivered via iron oxide magnetic nanoparticles (mNP) and an appropriately matched noninvasive alternating magnetic field (AMF). To explore the tumor radiosensitization potential of mNP hyperthermia we used a syngeneic mouse breast cancer model, dextran-coated 110 nm hydrodynamic diameter mNP and a 169 kHz / 450 Oe (35.8 kA/m) AMF. Intradermally implanted (flank) tumors (150 ± 40 mm³) were treated by injection of 0.04 ml mNP (7.5 mg Fe) / cm³ into the tumor and an AMF (35.8 kA/m and 169 kHz) exposure necessary to achieve a CEM (cumulative equivalent minute) thermal dose of 60 (CEM 60). Tumors were treated with mNP hyperthermia (CEM 60), radiation alone (15 Gy, single dose) and in combination. Compared to the radiation and heat alone treatments, the combined treatment resulted in a greater than two-fold increase in tumor regrowth tripling time (tumor treatment efficacy). None of the treatments resulted in significant normal tissue toxicity or morbidity. Studies were also conducted to compare the radiosensitization effect of mNP hyperthermia with that of microwave-induced hyperthermia. The effects of incubation of nanoparticles within tumors (to allow nanoparticles to be endocytosed) before application of AMF and radiation were determined. This preliminary information suggests cancer cell specific hyperthermia (i.e. antibody-directed or anatomically-directed mNP) is capable of providing significantly greater radiosensitization / therapeutic ratio enhancement than other forms of hyperthermia delivery.

Citation Download Citation

Andrew J. Giustini, Alicia A. Petryk, and Paul J. Hoopes "Comparison of microwave and magnetic nanoparticle hyperthermia radiosensitization in murine breast tumors", Proc. SPIE 7901, Energy-based Treatment of Tissue and Assessment VI, 79010E (22 February 2011); https://doi.org/10.1117/12.876515

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available